A randomised evaluation of low‐dose cytosine arabinoside (ara‐C) plus tosedostat versus low‐dose ara‐C in older patients with acute myeloid leukaemia: results of the LI‐1 trial

Low-dose cytosine arabinoside regimen induced a complete remission with normal karyotypes in a case with hypoplastic acute myeloid leukaemia with No. 8-trisomy: in vitro and in vivo evidence for normal haematopoietic recovery

British Journal of Haematology ◽

10.1111/j.1365-2141.1985.tb07442.x ◽

1985 ◽

Vol 60 (3) ◽

pp. 449-455 ◽

Cited By ~ 13

Author(s):

M. Tagawa ◽

J. Shibata ◽

M. Tomonaga ◽

T. Amenomori ◽

Y. Yoshida ◽

...

Keyword(s):

Complete Remission ◽

Acute Myeloid Leukaemia ◽

Myeloid Leukaemia ◽

Cytosine Arabinoside ◽

Low Dose ◽

Acute Myeloid

The addition of gemtuzumab ozogamicin to low-dose Ara-C improves remission rate but does not significantly prolong survival in older patients with acute myeloid leukaemia: results from the LRF AML14 and NCRI AML16 pick-a-winner comparison

Leukemia ◽

10.1038/leu.2012.229 ◽

2012 ◽

Vol 27 (1) ◽

pp. 75-81 ◽

Cited By ~ 109

Author(s):

A K Burnett ◽

◽

R K Hills ◽

A E Hunter ◽

D Milligan ◽

...

Keyword(s):

Acute Myeloid Leukaemia ◽

Myeloid Leukaemia ◽

Older Patients ◽

Low Dose ◽

Remission Rate ◽

Gemtuzumab Ozogamicin ◽

Acute Myeloid

A randomised comparison of the novel nucleoside analogue sapacitabine with low-dose cytarabine in older patients with acute myeloid leukaemia

Leukemia ◽

10.1038/leu.2015.38 ◽

2015 ◽

Vol 29 (6) ◽

pp. 1312-1319 ◽

Cited By ~ 24

Author(s):

A K Burnett ◽

N Russell ◽

R K Hills ◽

N Panoskaltsis ◽

A Khwaja ◽

...

Keyword(s):

Acute Myeloid Leukaemia ◽

Myeloid Leukaemia ◽

Nucleoside Analogue ◽

Older Patients ◽

Low Dose ◽

The Novel ◽

Low Dose Cytarabine ◽

Acute Myeloid

Hypoplastic acute myeloid leukaemia with 7 years of complete remission by low-dose cytosine arabinoside therapy alone

European Journal Of Haematology ◽

10.1111/j.1600-0609.1995.tb00235.x ◽

2009 ◽

Vol 55 (1) ◽

pp. 59-60 ◽

Cited By ~ 1

Author(s):

H. Mori ◽

K. Fuchigami ◽

K. Nagai ◽

T. Kohno ◽

T. Maeda ◽

...

Keyword(s):

Complete Remission ◽

Acute Myeloid Leukaemia ◽

Myeloid Leukaemia ◽

Cytosine Arabinoside ◽

Low Dose ◽

Acute Myeloid

Low dose cytosine arabinoside: partial remission of acute myeloid leukaemia without evidence of differentiation induction

British Journal of Haematology ◽

10.1111/j.1365-2141.1984.tb02899.x ◽

1984 ◽

Vol 57 (2) ◽

pp. 301-307 ◽

Cited By ~ 47

Author(s):

Michael Leyden ◽

Arumigum Manoharan ◽

Andrew Boyd ◽

Zhao Ming Cheng ◽

John Sullivan

Keyword(s):

Acute Myeloid Leukaemia ◽

Myeloid Leukaemia ◽

Cytosine Arabinoside ◽

Partial Remission ◽

Low Dose ◽

Differentiation Induction ◽

Acute Myeloid

Review of clinical and haematological response to low-dose cytosine arabinoside in acute myeloid leukaemia

European Journal Of Haematology ◽

10.1111/j.1600-0609.1987.tb01416.x ◽

2009 ◽

Vol 38 (1) ◽

pp. 3-11 ◽

Cited By ~ 12

Author(s):

Mordechai Shtalrid ◽

Joseph Lotem ◽

Leo Sachs ◽

Alain Berrebi

Keyword(s):

Acute Myeloid Leukaemia ◽

Myeloid Leukaemia ◽

Cytosine Arabinoside ◽

Low Dose ◽

Haematological Response ◽

Acute Myeloid

Tretinoin [all-trans retinoic acid] plus low-dose cytarabine [cytosine arabinoside] is efficacious in elderly patients with acute myeloid leukaemia

Inpharma Weekly ◽

10.2165/00128413-200716020-00042 ◽

2007 ◽

Vol &NA; (1602) ◽

pp. 14

Author(s):

&NA;

Keyword(s):

Retinoic Acid ◽

Elderly Patients ◽

Acute Myeloid Leukaemia ◽

Myeloid Leukaemia ◽

Cytosine Arabinoside ◽

Low Dose ◽

Trans Retinoic Acid ◽

All Trans Retinoic Acid ◽

Low Dose Cytarabine ◽

Acute Myeloid

Randomized trial of two schedules of low-dose gemtuzumab ozogamicin as induction monotherapy for newly diagnosed acute myeloid leukaemia in older patients not considered candidates for intensive chemotherapy. A phase II study of the EORTC and GIMEMA leukaemia groups (AML-19)

British Journal of Haematology ◽

10.1111/j.1365-2141.2010.08095.x ◽

2010 ◽

Vol 149 (3) ◽

pp. 376-382 ◽

Cited By ~ 36

Author(s):

Sergio Amadori ◽

Stefan Suciu ◽

Dominik Selleslag ◽

Roberto Stasi ◽

Giuliana Alimena ◽

...

Keyword(s):

Acute Myeloid Leukaemia ◽

Randomized Trial ◽

Myeloid Leukaemia ◽

Older Patients ◽

Low Dose ◽

Phase Ii Study ◽

Gemtuzumab Ozogamicin ◽

Intensive Chemotherapy ◽

Newly Diagnosed ◽

Acute Myeloid

The addition of low-dose cytarabine to clofarabine is beneficial in older patients with acute myeloid leukaemia (AML) and myelodysplastic syndromes

Inpharma Weekly ◽

10.2165/00128413-200816590-00041 ◽

2008 ◽

Vol &NA; (1659) ◽

pp. 16

Author(s):

&NA;

Keyword(s):

Acute Myeloid Leukaemia ◽

Myeloid Leukaemia ◽

Myelodysplastic Syndromes ◽

Older Patients ◽

Low Dose ◽

Low Dose Cytarabine ◽

Acute Myeloid

Continuous drip infusion of low dose cytarabine and etoposide with granulocyte colony-stimulating factor for elderly patients with acute myeloid leukaemia ineligible for intensive chemotherapy

Hematological Oncology ◽

10.1002/hon.834 ◽

2008 ◽

Vol 26 (1) ◽

pp. 33-38 ◽

Cited By ~ 7

Author(s):

Nobuhiro Kanemura ◽

Hisashi Tsurumi ◽

Senji Kasahara ◽

Takeshi Hara ◽

Toshiki Yamada ◽

...

Keyword(s):

Elderly Patients ◽

Acute Myeloid Leukaemia ◽

Myeloid Leukaemia ◽

Low Dose ◽

Intensive Chemotherapy ◽

Granulocyte Colony Stimulating Factor ◽

Colony Stimulating Factor ◽

Stimulating Factor ◽

Low Dose Cytarabine ◽

Acute Myeloid